Atara Biotherapeutics stock falls sharply after reporting big loss

You are here: Home > Biotech > Current Article

Atara Biotherapeutics stock falls sharply after reporting big loss

By Staff Report / Tuesday, February 26th, 2019 / Comments Off on Atara Biotherapeutics stock falls sharply after reporting big loss

Thousand Oaks biotech Atara Biotherapeutics announced an $80 million net loss, or $1.75 per share, in the fourth quarter of 2018, missing analyst estimates of $1.31 and sending shares tumbling 15 percent in early trading Feb. 26. The company reported a 151 percent increase in research and development costs to $62.3 million in the fourth…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.